Plain-English translation of NCT07354152 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
After surgeons remove melanoma (a serious type of skin cancer), they need to close the wound that's left behind. This study compares two common surgical methods: a skin graft (where healthy skin is moved to cover the wound) or a perforator flap (where nearby tissue with its own blood supply is moved to cover the area). Your surgical team will decide which method is best for your situation.
When melanoma is removed, surgeons sometimes can't close the wound by stitching the edges together. This study wants to understand which of these two standard closure methods works better for patients — helping doctors choose the best approach for future melanoma patients.
You likely qualify if…
You likely don't qualify if…
You would have already undergone melanoma removal surgery. Your surgical team (a multidisciplinary tumor board) will decide whether a skin graft or perforator flap is best for closing your specific wound. The study will then follow your recovery and compare how well each method works, tracking wound healing and other surgical outcomes over time.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
France
Enrollment target
~40 participants
Started
February 2026
Primary completion
May 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ugo Lancien, MD
Nantes University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.